Issue 43, 2007

Functionalised cyclopentadienyl titanium compounds as potential anticancer drugs§

Abstract

A number of new ionic titanocene compounds have been isolated and characterised, which exhibit excellent cytotoxicity against different human tumour cell lines including a defined cisplatin resistant cell line. A range of biological assays have been carried out to determine levels of cytotoxicity and levels of DNA interstrand crosslinking.

Graphical abstract: Functionalised cyclopentadienyl titanium compounds as potential anticancer drugs

Supplementary files

Article information

Article type
Paper
Submitted
31 May 2007
Accepted
06 Jul 2007
First published
19 Sep 2007

Dalton Trans., 2007, 5082-5090

Functionalised cyclopentadienyl titanium compounds as potential anticancer drugs

O. R. Allen, A. L. Gott, J. A. Hartley, J. M. Hartley, R. J. Knox and P. C. McGowan, Dalton Trans., 2007, 5082 DOI: 10.1039/B708283P

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements